Heterogeneity of tumor prognostic markers: A reproducibility study applied to liver metastases of pancreatic endocrine tumors

Modern Pathology

Volumn 22, Issue 2, 2009, Pages 273-281

  Couvelard, Anne ^a,c   Deschamps, Lydia ^a   Ravaud, Philippe ^b   Baron, Gabriel ^b   Sauvanet, Alain ^a   Hentic, Olivia ^a   Colnot, Nathalie ^a   Paradis, Valérie ^a   Belghiti, Jacques ^a   Bedossa, Pierre ^a   Ruszniewski, Philippe ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

Heterogeneity; Pancreatic endocrine tumors; Reproducibility; Tissue microarray

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; SOMATOSTATIN RECEPTOR 2; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CALCULATION; CLINICAL ARTICLE; CORRELATION COEFFICIENT; GLUCAGONOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULINOMA; LIVER METASTASIS; MICROVASCULATURE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SOMATOSTATINOMA; TISSUE MICROARRAY; TUMOR BIOPSY; TUMOR VASCULARIZATION;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; BIOPSY; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; MICROVESSELS; OBSERVER VARIATION; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RECEPTORS, SOMATOSTATIN; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 59149091793     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.177     Document Type: Article

References (37)

1. Madeira I, Terris B, Voss M, et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998;43:422-427.
2. Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394-424.
3. Tomassetti P, Campana D, Piscitelli L, et al. Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 2005;16:1806-1810.
4. Clarke MR, Baker EE, Weyant RJ, et al. Proliferative Activity in Pancreatic Endocrine Tumors: Association with Function, Metastases, and Survival. Endocr Pathol 1997;8:181-187.
5. Gentil Perret A, Mosnier JF, Buono JP, et al. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors. Am J Clin Pathol 1998;109:286-293.
6. Solcia E, Klöppel G, Sobin LH, (eds). Histological Typing of Endocrine Tumours, 2nd edition. WHO International Histological Classification of Tumours. Springer: Berlin, 2000.
7. DeLellis RA, Lloyd RV, Heitz PU, et al. (eds). World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. IARC Press: Lyon, 2004.
8. Rindi G, Couvelard A, Scoazec JY, et al. Practical notes for the evaluation of malignancy in digestive endocrine tumors. Ann Pathol 2005;25:487-498.
9. Rindi G, Kloppel G, Alhman H, et al., all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395-401.
10. Yasui H, Konishi E, Urasaki K, et al. Intratumoral heterogeneity of MIB-1 labelling index in gastric gastrointestinal stromal tumor (GIST). Gastric Cancer 2006;9:223-228.
11. Nasir A, Stridsberg M, Strosberg J, et al. Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility. Cancer Control 2006;13:52-60.
12. Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003;125:1094-1104.
13. Couvelard A, O'Toole D, Turley H, et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 2005;92:94-101.
14. Maeda K, Chung YS, Takatsuka S, et al. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995;72:319-323.
15. De Jong JS, van Diest PJ, Baak JP. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 1995;73:922-926.
16. De Jong JS, van Diest PJ, Baak JP. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000;36:306-312.
17. Prall F, Gringmuth U, Nizze H, et al. Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histopathology 2003;42:482-491.
18. Offersen BV, Borre M, Overgaard J. Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 2003;39:881-890.
19. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
22. Gillett CE, Springall RJ, Barnes DM, et al. Multiple tissue core arrays in histopathology research: a validation study. J Pathol 2000;192:549-553.
23. Milanes-Yearsley M, Hammond ME, Pajak TF, et al. Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups. Mod Pathol 2002;15:1366-1373.
24. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-1251.
25. Nocito A, Bubendorf L, Tinner EM, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-357.
26. Rosenau J, Bahr M, von Wasielewski R, et al. Ki-67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002;73:386-394.
27. Rodallec M, Vilgrain V, Couvelard A, et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 2006;6:77-85.
28. Fox SB. Tumour angiogenesis and prognosis. Histopathology 1997;30:294-301.
29. Fox SB, Harris AL. Histological quantitation of tumour angiogenesis. APMIS 2004;112:413-430.
30. Trivella M, Pezzella F, Pastorino U, et al. Prognosis In Lung Cancer (PILC) Collaborative Study Group. Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncol 2007;8:488-499.
31. McDonald DM, Choyke PL. Imaging of angiogenesis. Nat Med 2003;9:713-725.
32. Bottini A, Berruti A, Bersiga A, et al. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. Clin Cancer Res 2002;8:1816-1821.
33. Reubi JC, Kappeler A, Waser B, et al. Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets. J Clin Endocrinol Metab 1998;83:3746-3749.
34. Kimura N, Pilichowska M, Date F, et al. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res 1999;5:3483-3487.
35. Oda Y, Tanaka Y, Naruse T, et al. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors. Surg Today 2002;32:690-694.
36. Kubota A, Yamada Y, Kagimoto S, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994;93:1321-1325.
37. Volante M, Bozzalla-Cassione F, Papotti M. Somatostatin receptors and their interest in diagnostic pathology. Endocr Pathol 2004;15:275-291.